Novartis keeps a close eye on gene therapy with Vedere Bio buy
Already a major player in gene therapy, Novartis has swooped on US startup Vedere Bio in a $280 million deal that builds its position in […]
Already a major player in gene therapy, Novartis has swooped on US startup Vedere Bio in a $280 million deal that builds its position in […]
Shots: Vedere Bio received $150M as upfront payments and is eligible to receive up to $130M as milestones making a total deal value of $280M. […]
Intermountain Healthcare — one of the largest health systems in the country and among the most bullish on home-based care — is merging with Sanford […]
Stocks for Exact Sciences leaped 33% after it announced the acquisition of liquid biopsy rival Thrive and UK start-up Base Genomics. Exact Sciences said it […]
Shots: Exact Sciences to acquire Thrive in all cash & stock transaction for ~2.15B out of which $1.7B would be payable at closing, consisting of […]
Shots: Bayer acquires AskBio for $2B as upfront and ~2B as milestones with 75% of the milestones to be paid during the next five years. […]
Bayer is making clear its ambitions in cell and gene therapy with a $4 billion acquisition of US biotech Asklepios BioPharmaceutical, also known as AskBio. […]
Angels of Care, a home health provider that specializes in caring for pediatric patients with complex medical conditions, announced Thursday that it has entered into […]
Two years after quietly forming cancer start-up Nuvation Bio, ex-Axovant and Medivation CEO David Hung has agreed a big merger that will take it public […]
Shots: StageBio and TPL Path Labs offers an expanded array of histopathology, molecular pathology, and related solutions to biopharma, medical device and academic researchers across […]
M&A activity across home health, hospice and in-home care appeared to be “business as usual” at the start of 2020. COVID-19 froze the market in […]
Shots: Endo to acquire all the outstanding shares of BioSpecifics for $88.50/ share in cash, making a total deal value of $540M. The transaction is […]
Shots: Lilly to acquire Disarm for $135M upfront and ~$1.225B as potential development regulatory and commercial milestones, making a total deal value of ~1.36B The […]
LHC Group Inc. (Nasdaq: LHCG) has inked another joint venture agreement. On Thursday, the Lafayette, Louisiana-based home health, hospice and personal care services provider announced […]
WellSky announced Tuesday it has entered into an agreement to acquire CarePort Health from Allscripts Healthcare Solutions (Nasdaq: MDRX), a health care information technology provider. […]
Charter Health Care Group — a PE-backed post-acute care platform company with multiple locations across five states — announced Tuesday the acquisitions of both Vitality […]
Clover Health recently announced that it will go public through a merger with a special purpose acquisition company (SPAC), Social Capital Hedosophia Holdings Corp. III. […]
Bridges announces series of mergers Los Angeles-based Bridges Health Services has announced a series of new merger agreements. In Nevada, Bridges will join forces with […]
The companies expect the deal to close in the fourth quarter. MyoKardia’s lead drug candidate is mavacamten, which it is developing for hypertrophic cardiomyopathy and […]
Alivia Care Inc., a new operator in the senior care space, has plans to enter the home health market. Launched at the end of September, […]
Bristol-Myers Squibb has said it will buy biotech MyoKardia in a $13.1 billion takeover that marks a step up in its development of cardiovascular drugs. […]
Shots: BMS to acquire all the outstanding shares of MyoKardia’s common stock for $225.00/ share in cash, making a total deal value of ~$13.1B. The […]
Shots: STADA acquires Lobsar and its innovative therapy to foster its footprints in specialty pharmaceuticals. The acquisition complements STADA’s portfolio and expertise in the treatment […]
Shots: Philips will acquire Intact Vascular for $275M up front and deferred payments of $85M upon completion of the transaction. The transaction is expected to […]
LHC Group Inc. (Nasdaq: LHCG) has added another joint venture partner into its fold. The Lafayette, Louisiana-based home health, hospice and personal care services provider […]
Shots: ACADIA acquires all outstanding shares of CerSci for $52.5M. CerSci may receive up to $887M as development, commercialization milestones along with royalties on sales The […]
Shots: Lineagen to receive $9.6M consisting of 6,167,510 shares of Bionano’s common stock, ~ $1.7M in cash and assumption of ~$2.9M in liabilities. The acquisition […]
With the ink barely dry on a deal to develop Dragonfly’s lead cancer immunotherapy, Bristol-Myers Squibb’s business development team has agreed to buy Canadian biotech […]
Takeda has joined the ranks of big pharma companies jettisoning consumer health businesses in order to concentrate on higher-margin prescription drugs. The drugmaker is divesting […]
Caring People is staying busy on the acquisition front. In fact, the New York City-based Caring People has completed a handful of strategic deals — […]
Johnson & Johnson is to buy Momenta Pharmaceuticals for $6.5 billion, adding potential inflammatory diseases blockbuster nipocalimab to the pipeline at its Janssen pharmaceuticals unit. […]
Shots: J&J acquires Momenta in all-cash transaction at a price of $52.50/ share, making a total deal value as $6.5B. The transaction is expected to […]
Carely Inc. — an online referral platform for both caregivers and professional care providers — has announced it has an agreement in place to acquire […]
Shots: Sanofi to acquire Principia Biopharma in an all-stock transaction, at $100/share making total deal value ~$3.68B in cash. The transaction is expected to be […]
Sanofi is to buy Principia Biopharma for up to $3.68 billion, adding a potential multiple sclerosis drug to its pipeline. The French pharma said it […]
M&A has been quiet in home health care for the most part, mostly due to the implementation of the Patient-Driven Groupings Model (PDGM) and the […]
So far, the transition to the Patient-Driven Groupings Model (PDGM) has gone smoothly for many home health agencies, with a majority successfully avoiding questionable encounters […]
Shots: The acquisition will expand Medtronic’s capabilities to serve people using multiple daily injections (MDI) to manage diabetes with the addition of Companion Medical’s InPen […]
Shots: Ligand to acquire all outstanding shares of Pfenex for $12/share in cash or $438 million in equity value with a 57% premium to the […]
Shots: KaNDy to receive $425M upfront, ~$450M milestones until launch followed by additional commercial milestones. The transaction is expected to be completed in Sept’2020 The […]
Shots: The acquisition will expand Olympus’ offerings in GI therapeutic devices and the development of advanced colonoscopy tools with the aim of improving early detection […]
Bayer is to buy UK-based KaNDy Therapeutics in a deal worth more than $800 million, adding the biotech’s menopause drug to its women’s health pipeline. […]
When it comes to acquiring home health care agencies, buyers can afford to be picky. There are more than 10,000 home health providers nationwide, but […]
– Healthcare Growth Partners’ (HGP) summary of Health IT/digital health mergers & acquisition (M&A) activity, and public company performance during the month of July 2020. […]
Since the worst stretch of the public health emergency, LHC Group Inc. (Nasdaq: LHCG) has seen a decrease in weekly COVID-related missed visits and improved […]
Shots: Siemens Healthineers to acquire Varian in an all-cash transaction, at a price of $177.50/ share with 42% to the 30-day volume-weighted average closing price […]
The COVID-19 emergency has slowed mergers-and-acquisitions activity in the home-based care space, largely due to travel restrictions, general sector uncertainty and the shifting priorities of […]
Health and well-being company Humana Inc. (NYSE: HUM) has spent the past few years adding to its health care services portfolio while aggressively investing around […]
Pfizer has cautiously upped its guidance despite second quarter figures showing a slip in sales and profitability compared with the same period last year. Revenues […]
Despite the economic turmoil of the ongoing COVID-19 emergency, home health and hospice multiples hit record-breaking numbers in the first half of 2020. Specifically, multiples […]
Shots: Sorrento enters into letter of intent to acquire SmartPharm and develops pipeline of gene-encoded therapeutic Ab, initiating with Sorrento’s STI-1499 or COVI-GUARD, currently preclinical […]
Increasingly, home health providers have worked to expand their service offerings to care for patients on a more longitudinal basis. Mergers-and-acquisitions activity in the second […]
Gilead Sciences’ run of oncology-focused deals has continued with an option to buy cancer immunotherapy specialist Tizona – even though the biotech’s lead drug candidate […]
Shots: Gilead invests $300M to obtain 49.9% equity interest in Tizona and receives an exclusive option to acquire remaining stakes of Tizona for up to […]
Private equity-backed health care software company WellSky has a new investor and a new capital structure, the company announced Monday. TPG Capital — the PE […]
Shots: Under the amended agreement, the offer price increased from $44.5 to $49/QIAGEN share in cash, representing a premium of 35% to the closing price […]
Shots: Gilead to receive an up front in cash and convertible notes into Kronos equity, regulatory & commercial milestones along with royalties on sales of […]
Bayada Home Health Care on Thursday announced plans to form a new joint venture with Universal Health Services Inc. (NYSE: UHS), one of the largest […]
Healthcare Growth Partners, an Investment Banking and Strategic Advisory firm exclusively focused on the transformational health IT market, today announced the release of its Semi-Annual Health […]
Smaller home-based care agencies could be forced to close their doors as a result of the coronavirus, creating merger-and-acquisition opportunities for larger providers in the […]
Pre-coronavirus, the home health and home care industries were already poised for historic consolidation, thanks to the Patient-Driven Groupings Model (PDGM), rising minimum wages and […]
Copyright © 2024 | WordPress Theme by MH Themes